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Emergency departments (EDs) are the only source of medical care for many adults and 
have been found to be feasible venues for vaccinating high-risk patients against seasonal 
influenza. Since the CDC guidelines expanded in 2008 to include any adults wishing to 
protect themselves and those around them from the flu, the vaccination of low-risk 
patients in the ED has not been evaluated. This study sought to assess the acceptability 
among adult patients of all ages for vaccinating against seasonal influenza in the Urgent 
Care area of an urban ED, which treats primarily healthy adults.  A convenience sample 
of adult patients in the Urgent Care area was surveyed in November 2009.  Subjects were 
asked about their vaccination history, as well as their perceived need and potential 
acceptance of a vaccine in the ED. Demographic data obtained included age, race, 
education, insurance status, medical history, access to primary care and contact with 
high-risk individuals.  381 patients were approached, of whom 352 completed the survey 
(92.4%; 56% male, 44% female; mean age 36 years, Standard Deviation 12.4), and 349 
were vaccine-eligible. 250 (72%) denied any significant medical history. While 169 
patients (48.4%) had an influenza vaccination history, only 69 (20%) were vaccinated in 
2009. Of the 280 not vaccinated this year, 179 (64%) would have accepted the vaccine in 
the ED.  Factors associated with increased odds of vaccine acceptance in the ED 
included: age younger than 50 years (Odds Ratio [OR] 3.28, 95% Confidence Interval 
[CI] = 1.74 to 6.21, p<0.01), Latino/Hispanic ethnicity (OR 2.89, 95% CI = 1.52 to 5.51, 
p<0.01), and close contact with high-risk individuals (OR 2.28, 95% CI = 1.33 to 3.92, 
p<0.01).  These results suggest that the majority of relatively healthy adult patients would 
accept the seasonal influenza vaccine in the ED.  Although a shortage of vaccines and 
increased vigilance during a concurrent H1N1 outbreak may have influenced overall 
acceptability, we conclude that influenza vaccinations during the ED patient encounter 
would generally be acceptable to patients as a means to improve their overall health, and 
indirectly the health of their high-risk close contacts.  
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Introduction 
Background & Current Influenza Immunization Practices 
Despite vaccination efforts since the 1960s, seasonal influenza continues to be a major 
cause of morbidity and mortality worldwide.  An estimated 36-51,000 influenza-related 
deaths occur each year in the United States, accounting for over $87 billion lost, of which 
over $10 billion are direct medical costs1-3. As our population ages, these numbers will 
undoubtedly climb.  Influenza vaccines have the potential to prevent 50-60% of 
laboratory-confirmed influenza in community-dwelling elderly persons over the age of 
65, while reducing their risk of death by 48% and their risk of influenza- or pneumonia-
related hospitalizations by 27%4, 5.  In adults younger than 65, the vaccine is even more 
effective, capable of preventing as much as 70-90% of laboratory-confirmed influenza 
cases4.   
 
Vaccination efforts have traditionally been targeted at individuals with an increased risk 
of complications associated with influenza (children younger than five, adults over 50, 
and persons with chronic medical illnesses).  Although the vaccine has also been 
recommended for contacts of high-risk individuals since 1985, formal targeted efforts to 
vaccinate such healthy individuals have only been directed at healthcare workers, not 
household or other close contacts. In 2008, the Advisory Committee on Immunization 
Practices (ACIP), a working group within the US Center for Disease Control and 
Prevention (CDC), expanded its recommendations to also include vaccination of “any 
adult who wants to reduce the risk of becoming ill with influenza or of transmitting it to 
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others,” as well as vaccination of all children 5-18 years old, while maintaining a primary 
focus on those 6-59 months old (Figure 1).   
 
The 2009 National Health Interview Survey (NHIS) found that only 34.9% of adults had 
been vaccinated against the flu for that season.  By age, the vaccination trends within the 
prior 12 months were 67.6% of adults older than 65 years, 41.7% of 50-64 year-olds, and 
22.9% of 18-49 year-olds.  Significant disparities were also found among racial and 
ethnic groups.   In the high-risk age bracket of adults over the age of 65 years, only 
51.5% of Hispanic/Latino individuals and 52.3% of non-Hispanic/Latino black 
individuals had been vaccinated, compared to 70.2% of non-Hispanic/Latino white 
individuals6. When considering other at-risk groups, the NHIS, the National 
Immunization Survey, and the Behavioral Risk Factor Surveillance System (BRFSS) 
survey report that only 25.5%-to-35.1% of high-risk 18-49 year-olds, 13.4% of pregnant 
women, and 17% of adult household contacts of high-risk individuals were vaccinated in 
the 2006-2007 season7-9. While the numbers for vaccinated adults (both high-risk and 
their close contacts) are slowly rising, they continue to fall far short of the Healthy People 
2010 national health objectives set by the US Department of Health and Human 
Services8, 10.  These goals include 90% coverage for persons older than 65 years and 
nursing home residents, as well as 60% coverage for non-institutionalized high-risk 18-49 
year-olds8, 10, 11.   
 
Annual influenza vaccination has long been indicated for elderly persons due to their 
increased rates of complications associated with the flu8.  Among the elderly, a 2006 
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Cochrane meta-analysis by Rivetti et al. found the vaccine to be significantly more 
effective in preventing pneumonia, hospital admission and death resulting from influenza 
in those who reside in long-term care facilities, as opposed to those who live in the 
community12.  This was in contrast to results found by Nichol et al. showing that the 
benefit favored those who are community-dwelling5.  Regardless of the contradictory 
findings, elderly persons are at greater risk for influenza-related complications, and 
should therefore be vaccinated.   
 
However, the individual vaccination of such high-risk persons may be insufficient to 
provide them with protective immunity.  Even during influenza seasons when the vaccine 
efficacy for the circulating virus is as high as 70-90%, the senescent immune systems of 
elderly patients may not produce adequate immunogenic responses13-15.  Goronzy, et al. 
quantified this among a cohort of 65-98 year-olds receiving the trivalent influenza 
vaccine.  Only 17% of them were able to generate proper antibody titers to all three 
components of the vaccine, and 46% produced no antibody response at all16.  When 
considering chronic illness in addition to advanced age, the variability of a vaccine-
generated humoral immunity is further amplified.  During the 2003-2004 influenza 
season, Herrera et al. evaluated vaccine effectiveness in 50-64-year-old adults with and 
without high-risk medical conditions.  Although the vaccine was 60% effective in 
preventing laboratory-diagnosed influenza in the healthy adults, it was only 48% 
effective in adults with high-risk medical conditions.  This translated into 90% vs. 36% 
effectiveness in preventing influenza-related hospitalizations in healthy vs. high-risk 
adults, respectively13.  To further this association, after following a cohort of over 72,000 
! "!
adults over the age of 65 for eight years, Jackson et al. reported that the historic 
misperception that the influenza vaccine protects senior citizens from illness and death 
related to the flu may have been biased by healthy seniors actually being more likely to 
be vaccinated than those who had medical problems in the first place17.  They also found 
that functional limitations (i.e. being unable to perform activities of daily living, such as 
bathing oneself) of seniors over the age of 65 were associated with a lower likelihood of 
influenza vaccination, as well as an increased risk of death during the influenza season18.  
 
Potential Changes in Vaccination Practices to Improve Outcomes in the Community 
The aforementioned studies demonstrate that vaccination of high-risk patients actually 
provides them with only limited immunity against influenza.  Even if vaccination rates do 
reach the Healthy People 2010 goals, they may still be insufficient for improving overall 
societal health.  In fact, a cyclic regression model conducted by Simonsen et al. found 
that despite an increase in vaccination rates from 15% in 1989 to 65% in 1997, there were 
no significant decreases in excess mortality among elderly and chronically ill 
populations19. If vaccinating the high-risk populations is not sufficient to decrease their 
morbidity and mortality, perhaps preventive measures should be refocused to stop the 
initial transmission of the virus to these individuals.  Rather than relying on their own 
immune systems to protect them from illness, a general decrease in the amount of 
circulating virus in the community could prevent them from being exposed to influenza 
in the first place.  In 2009, Medlock and Galvani created a mathematical model to 
account for “age-specific transmission dynamics” during the 1918 and 1957 influenza 
pandemics.  The results of their analysis showed that vaccine distribution to school-aged 
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children and 30-to-39-year old adults would produce the most optimal outcomes in total 
influenza-associated infections and deaths.  This beneficial effect would also extend to 
years of life lost, economic costs (including future lifetime earnings) and contingent 
value (accounting for the death of young adults resulting in greatest societal disutility)20.  
While this data is based on outdated life expectancies and causes of mortality in the 
United States, they suggest a beneficial role for vaccinating society’s non-high risk 
individuals.  In recognition of these benefits, the ACIP influenza vaccination guidelines 
should extend support beyond just the vaccination of persons at increased risk for 
complications of the flu.  Promoting the vaccination of young healthy people in the 
community could accomplish just that goal. 
 
The overall health of the community can be improved by empowering individuals of all 
ages to protect their own health through acquired personal immunity, as well as the health 
of those around them through a decrease in transmission of the virus to their at-risk close 
contacts.  Since the CDC first recommended immunization of healthy household contacts 
of high-risk persons in 1985, numerous studies have evaluated the costs and benefits of 
vaccinating non-high risk individuals.  Results vary among cost-benefit analyses 
evaluating the vaccination of healthy working adults. The greatest financial burden was 
found by Bridges et al., who reported a net cost of $11.57 per person administered the 
vaccine (as compared to those receiving placebo).  This sum included the costs of 
vaccines and their administration, as well as the cost of physicians’ visits, prescriptions, 
hospitalizations and lost work hours secondary to influenza illness21.  Notably, this net 
financial cost per person was also associated with the intangible benefits of 34% fewer 
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influenza-like illnesses (ILI), 42% fewer physician visits and 32% fewer work days lost 
during years with a good vaccine match (86% efficacy) for circulating viruses.  However, 
the cost jumped to $65.59 during years with a poor match (50% efficacy).  The authors 
also noted that the likelihood of net savings would be increased if one took into account 
the decreased rate of viral transmission to close contacts, as well as improvement in 
quality of life21.  In contrast, the greatest net savings were found by Nichols et al, who 
reported $46.85 saved per healthy adult receiving the vaccine (as compared to those 
receiving placebo), and observed reductions in the number of work days lost by 43% and 
the number of physician visits by 44%22.   
 
The potential to improve overall public health by vaccinating of a threshold number of 
individuals demonstrates a concept known as herd immunity.  Herd immunity has been 
successful in combating a number of other infectious diseases, including varicella-related 
diseases, adult pneumococcal pneumonia, and hepatitis A.  There are also promising 
examples reporting that this concept could work with influenza.  In one neighborhood in 
Moscow, a single dose of inactivated vaccine was provided to 57% of 3-6 year-old and 
72% of 7-17 year-old children. When compared to a control neighborhood, in which 
children were not vaccinated, non-vaccinated elderly had 3-4 times fewer episodes of 
influenza-like illnesses when the children in their neighborhood were vaccinated23.  In 
another study conducted by Reichert, et al., vaccination of Japanese schoolchildren 
against influenza led to an overall decrease in winter mortality, with an estimated 37-
49,000 lives spared between 1977 and 1994. Further proof of this direct correlation came 
after the discontinuation of this program in 1994, when the effects on annual mortality 
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were quickly reversed24. Providing yet another example, the vaccination of day-care 
children (24-60 months old) in San Diego, California was associated with a 42% 
reduction in febrile illnesses among all unvaccinated household contacts of these 
children, and a greater that 70% decrease in febrile respiratory illnesses, school 
absenteeism, earaches, physician visits, and antibiotic prescriptions among school-aged 
contacts25. Lastly, Weycker and colleagues evaluated the potential herd benefits of 
vaccinating children by a computer simulation model of influenza transmission and found 
that vaccinating just 20% of children would reduce the total number of influenza cases by 
46%, while vaccinating 40% would decrease morbidity and mortality in the elderly by up 
to 70%26.  
 
Extending this concept from just children to the general population should only improve 
the potential to prevent influenza-related illnesses.  In 2000, Ontario, Canada 
implemented the world’s first universal influenza immunization program (UIIP).  As a 
result, the province experienced a 74% decline in influenza-associated mortality between 
1997 and 2004 (other Canadian provinces only had a combined 57% decline)27. This 
dramatic improvement was also seen in the number of influenza-associated 
hospitalizations, doctor’s office visits and emergency department visits27.   In light of 
these proven benefits to vaccinating healthy individuals, efforts should be made to at least 
increase the vaccination rates of household contacts to high-risk persons far beyond its 
most peak rate in the United States of 21.1% in 200428. 
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Evaluating Influenza Vaccination Programs in the Emergency Department 
In the United States, where access to primary and preventive health care services is 
limited, one way to improve vaccination rates may be to make these services available 
through the emergency department.  The role for vaccinations in the ED is widely 
recognized and accepted, although the extent to which such services are provided is a 
topic of debate.  The emergency department has historically offered vaccinations against 
tetanus and rabies.  Occasionally hepatitis, measles, mumps, rubella, cholera, and 
meningococcus have also been available.  In the past decade, 93% of emergency 
department vaccinations were against tetanus, as one in three patients with open wounds 
in the ED receives this vaccine29.  As a result, in 2009, there were only 17 reported cases 
of tetanus in the US30.  Meanwhile, 114,000 hospitalizations and up to 51,000 deaths 
occur each year secondary to influenza29.  In an effort to expand influenza vaccination 
coverage the ACIP’s 2008 Recommendations on Prevention and Control of Influenza 
included a statement that: “Acute health-care facilities (e.g., emergency departments and 
walk-in clinics) should offer vaccinations throughout the influenza season to persons for 
whom vaccination is recommended or provide information regarding why, where, and 
how to obtain” the vaccine8. The American College of Emergency Physicians (ACEP) 
supports the establishment of relationships between emergency departments and 
outpatient clinics/physicians in order to refer unvaccinated patients, as well as the role of 
EDs in assisting with vaccination campaigns in the event of an epidemic or outbreak of a 
vaccine-preventable disease, such as influenza31.  Given the annual occurrence of 
influenza epidemics, and the inability to predict the severity of viral pathogenicity in a 
given year, EDs would better serve their patients by establishing programs to offer the 
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vaccine annually.  Making this a part of the standard of care each flu season may also 
better prepare EDs to distribute other vaccines in the event of new infectious disease 
outbreaks. Furthermore, greater vaccination coverage of the emergency department 
patient population would be a step toward breaking down the health barriers associated 
with lack of means and medical coverage.  
 
For many Americans, the emergency department serves as their only point of contact 
with the health care system.  According to the most recently published National Hospital 
Ambulatory Medical Care Survey (NHAMCS), there were over 120 million visits to 
hospital emergency departments in the United States in 2006 (up 32% from the 90.3 
million visits ten years prior), and overall utilization is continuing to rise with 40.5 visits 
per 100 persons annually32.   With recent economic struggles nationwide, the percent of 
people with a regular place to go for medical care (not including a hospital ED) has 
decreased from 87.9% in 2003 to 85.4% as of June 2009, with Hispanic/Latino adults 
being the most underserved at 76.3%6.  Of those patients who have primary medical 
doctors (PMDs), a survey in 2002 showed that while 80% of their physicians offered the 
vaccine in their practices, only one-fourth used a telephone or mail reminder system to 
contact their high-risk patients regarding the need for annual vaccination33.  Because 
immunization is time-dependent, requiring about two weeks to ensure a proper immune 
response prior to viral exposure, a lack of contact with one’s PMD in the months 
preceding flu season provides the same benefit as the absence of a PMD altogether.   
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Given their access to a large portion of the population, emergency departments have the 
potential to help fill this great void in public health.   In a recent evaluation of risk status 
among ED patients in a Tucson, Arizona ED, Hiller et al. found that the ED population 
had a greater risk for influenza-related complications than the general adult population. 
Medically high-risk patients (including those who are pregnant) comprised 41.5% of that 
ED population, compared with 30.8% of the general population.  Still only 43.5% of 
those who were high-risk had been vaccinated.  Interestingly, 13.7% of the high-risk 
patients presenting to the ED during the peak of the influenza season (February 1-7) in 
2006 also had at least one visit to the ED during the preceding three months.  They 
therefore could have potentially avoided their subsequent visit by vaccination at that 
time34.  Clearly the ED patient population is in particular need of additional preventive 
health services in order to avoid the need for future such visits.   
 
Several studies have been conducted to evaluate the acceptability and feasibility of 
administering influenza vaccines (often alongside pneumococcal vaccines) among high-
risk adult patients in the emergency department (Table 1).  The first study to address this 
question came in the form of a questionnaire distributed by Polis, et al. over two decades 
ago, when only 20.1% of the 350 surveyed high-risk patients had even heard of a vaccine 
against the flu35.  Years later, in the fall of 1992, Rodriguez and Baraff were the first to 
attempt an actual influenza vaccination program in the emergency department at the 
University of California-Los Angeles (UCLA).  Over eight weeks, they examined a 
convenience sample of 763 patients over the age of 65, 63% of whom had not received 
the vaccine that season or were unsure of their vaccination status. Of those unvaccinated 
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patients, 50% consented to and received the vaccine after contraindications were ruled 
out36. In 1996, Slobodkin and his colleagues at the Cook County ED in Chicago, Illinois 
screened 24% of non-emergency patients (a sample size of 2631 persons) in the ED over 
6 weeks, and by standing order, offered the influenza and pneumococcal vaccines to 
patients at high risk for influenza-related complications. Thirty percent of the patients 
screened were found to be high risk, but only 21% had already received the vaccine.  
Ultimately, 62% percent of the non-immunized patients actually received the vaccine in 
the emergency department, although 71% had given consent37. In 2001, Pearson and her 
colleagues at the Emergency Department of Sir Mortimer B Davis Jewish General 
Hospital in Montreal, Quebec conducted a similar study over four weeks early in the 
influenza vaccination period. Thirty-six percent of those screened (754 patients) were 
considered eligible for the vaccine based on age or chronic disease, but only 35% of them 
had already received it.  Of those who were not already vaccinated, and had no plan to do 
so, 65% accepted the vaccine in the ED38.  In 2003, Rimple, et al. sought to immunize 
high-risk patients over a 3 week period at an urban ED in Albuquerque, New Mexico. 
Sixty-nine percent of the 648 patients who completed screening were found to be at high 
risk for influenza-related complications.  Of these, only 16% had already been 
vaccinated, a number which increased to 83% when the vaccine was offered and 
administered in the ED39. Most recently, Cassidy et al. screened 2858 ED patients in a 
private, urban hospital in Baton Rouge, Louisiana during the 2005-2006 flu season and 
reported a 25% rate of up-to-date vaccination status.   Of those who had not yet been 
vaccinated 46% were found to be high-risk, of whom 54% agreed to a vaccine in the ED, 
and 39% were actually vaccinated. When evaluating reasons for acceptance, 50-64-year-
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olds with a history of prior immunization were more likely to accept the vaccine, as were 
patients with co-morbidities, and those approached earlier in the flu season (December vs 
January/February)40.   These studies all confirm that although vaccination rates have 
varied greatly in both the United States and Canada, they have long been below adequate 
for high-risk patients. High-risk patients presenting to the ED without up-to-date 
vaccinations generally accepted seasonal flu vaccines during their visit.    
 
Through the years, patients sited many different barriers to accepting an influenza 
vaccine in the ED (Table 1).  Among these were: a perceived lack of need for the 
vaccine37, 39, 41, 42, concern of adverse reactions/side effects35-37, 39, 41, 42, belief that the 
vaccine actually causes the flu35, 37, belief that the vaccine does not work37, 38, and a desire 
to discuss their decision with their PMD36, 38, 41.   
 
While all the previously conducted studies verify the acceptability and feasibility of 
influenza vaccinations among high-risk patients in the ED, they are based on outdated 
CDC ACIP vaccination guidelines, which only accounted for vaccination of such high-
risk groups.  This researcher found no studies in the United States to evaluate the 
acceptability of the vaccine among young and healthy adult patients in the emergency 
department.  In an effort to decrease overall morbidity and mortality associated with 
seasonal influenza, a month-long survey was conducted in the Urgent Care area of the 
Yale-New Haven Hospital Emergency Department to evaluate the acceptability of the 
vaccine among this patient population.  
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Statement of Purpose 
The purpose of this study was to assess the acceptability of seasonal influenza 
vaccinations among the various demographic groups of patients in the urgent care area of 
the emergency department.  As part of this evaluation, we sought to also assess the 
barriers to patients accepting an influenza vaccination in the emergency department.  
Ultimately the study should answer the question of whether emergency departments 
could better serve their patients, and their patients’ close contacts at high-risk for 
complications of influenza, by filling this unmet immunization need in primary and 
preventive care. 
 
Hypothesis 
The majority of unvaccinated healthy adults presenting to the Urgent Care section of the 
Emergency Department would be willing to accept a seasonal influenza vaccine during 
visits for other uncomplicated medical issues.   
 
Specific Aims 
This study sought to assess influenza vaccination rates among relatively healthy adults in 
a socioeconomically and ethnically diverse urban community.  Among unvaccinated 
adults, especially those who are at high-risk for complications of the flu or in close 
contact with such individuals, we sought to identify factors associated with gaps in 
seasonal influenza vaccination status. The overall aim was to evaluate the acceptance of 
influenza vaccines by patients during this encounter with the medical system.   
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Methods 
Study Design and Administration 
A convenience sample of adult patients was surveyed during the month of November 
2009 in the Urgent Care area of an urban ED serving over 70,000 adults per year.  The 
Urgent Care area is open from 8 a.m. to 10 p.m. daily, and a medical student distributed 
surveys to patients awaiting test results or contact with their care provider during a total 
of forty hours each week.  Prior to survey administration, all subjects were provided 
information on the study and given the option to decline.  All information sheets and 
surveys were translated into Spanish, and the surveying medical student was proficient in 
Spanish.   
 
The survey consisted of questions about patients’ vaccination history, their perceived 
need for the vaccine, and whether they would accept a vaccine in the ED (Figure 2).  If 
unwilling to accept the vaccine in the ED, patients were also asked their reasons for 
refusal. This was presented as an open-ended question during the first two weeks of the 
study, and standardized options (including “other”) were provided during the second two 
weeks.   Demographic data obtained included age, race, education level, insurance status, 
and access to primary medical care.  Information was also collected to assess patients’ 
risk for complications associated with influenza, as well as their contact with high-risk 
individuals.  Patients requesting additional information about the seasonal influenza 
vaccine were given Yale-New Haven Hospital-prepared information sheets about the 
vaccine.  Because there was a shortage of available seasonal influenza vaccines during 
the course of this study, there were none available to distribute to patients in the ED.  
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Interested patients were referred to other vaccination locations through the Flu Vaccine 
Locator on a website run by the Department of Health and Human Services43.   
 
Statistical Analysis 
All data were entered into Microsoft Excel 2008 for Mac, Version 12.1.0 (Copyright 
2007, Microsoft Corporation).  Data were then transferred to Small Stata 11.0 for Mac 
(Copyright 2009, StataCorp) for all descriptive analysis.  Univariate analysis was 
conducted to determine odds ratios with 95% confidence intervals for the following 
dependent variables:  vaccination status this year, vaccination status in previous years, no 
history of vaccination ever, belief that one should be vaccinated, plans for vaccination, 
and willingness to receive a vaccine during their visit to the emergency department that 
day. The independent variables included: age, sex, race/ethnicity, insurance status, 
educational background, access to primary care, medical indications for vaccination, and 
contact with individuals at increased risk for complications of the flu.  Variables were 
dichotomous, with binomial data entry to document presence or absence of a variable.  
Chi-squared testing was used to calculate p-values, with significance being considered at 
p<0.05.  
 
Ethical Considerations 
This study was approved with expedited review by the Human Investigation Committee 
at the Yale University School of Medicine.  No signed informed consent was required 
since no medical interventions were made, all patient data were unidentifiable, and 
survey responses were confidential.  After being given an information sheet and a chance 
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to ask questions, patients were given the option to decline responding to the survey with 
no resulting prejudice affecting their medical care.  
 
Results 
A total of 381 patients were approached, of which 352 completed the survey (92.4% of 
those asked).  349 patients (99% of those surveyed) had no contraindications to the 
vaccine, and the three patients who had contraindications were all allergic to egg 
products.  The final surveyed sample used in this analysis was composed of 197 males 
(56%), and the mean age was 36 years ± Standard Deviation (SD) 12.4 years.  Table 2 
presents the demographic breakdown of survey respondents.  The majority of patients 
were younger than 50 years (292 persons, 83.7%).  The most common racial/ethnic group 
was black (non-Hispanic), comprising 36.1% of the populations (126 persons), while 
whites made up 30.7% (107), and Hispanic/Latino persons made up 27.2% (95).  Most 
patients had some form of health insurance (253 persons, 72.4%), either private (93 
persons, 26.6%) or government-sponsored (160 persons, 46.8%).  Eighty-four patients 
(24.1%) had no form of healthcare coverage.  One hundred eighty (51.6%) had a primary 
medical doctor.  Most patients (266 persons, 76.2%) were high school graduates or had 
passed a General Education Development (GED) test.    
 
One hundred fifty-eight (45.3%) had a history of vaccination against seasonal influenza 
in previous years, but only 69 (19.8%) had already been vaccinated for this influenza 
season (Table 2).  The rate of vaccination improved over the course of this month-long 
study, from 16% during the first half of the month to 24% during the latter half (Table 3). 
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Of those who had previously been vaccinated, 20 (12.6%) reported feeling sick after 
receiving the vaccine in the past, but none reported serious adverse reactions such as 
Guillain-Barré syndrome, or anaphylaxis.  Of 280 (80.2%) who had not yet been 
vaccinated this year, 116 (41%) believed they should be vaccinated, 107 (38%) already 
had plans to receive the vaccine this year, and 179 (64%) would have accepted the 
vaccine in the ED (Table 2).  
 
One hundred eighty patients (51.6%) reported never having been vaccinated against 
seasonal influenza.  Of these patients, 49 (27.2%) have a chronic medical condition 
placing them at increased risk for complications of the flu, and 121 (67.2%) have close 
contacts at increased risk for complications of the flu, of which 78 (64.5%) would have 
accepted a vaccine in the ED.  In total, 92 (51.1%) of the patients who had never been 
vaccinated believe that they should be vaccinated, 55 (30.6%) were planning to receive 
the vaccine this season, and 108 (60%) would have accepted the vaccine during that visit 
to the ED (Table 4).   
 
As shown in Table 5, previously vaccinated patients had greater odds of being vaccinated 
this year (Odds Ratio [OR] 9.49, 95% Confidence Interval [CI] = 4.49 to 20.06, p<0.01).  
In addition, if they had not yet been vaccinated, their odds were greater for believing that 
they should be vaccinated (OR 2.72, 95% CI = 1.57 to 4.71, p<0.01), and already having 
plans to obtain the vaccine this year (OR 2.46, 95% CI = 1.47 to 4.13), as compared with 
those who had never been vaccinated (OR 0.37, 95% CI = 0.21 to 0.64, p<0.01 believing 
they should be vaccinated; OR 0.41, 95% CI = 0.24 to 0.68, p<0.01 with plans).  These 
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trends carried over to willingness to accept a vaccine in the ED, but were not statistically 
significant (OR 1.63, 95% CI = 0.96 to 2.77, if previously vaccinated; OR 0.61, 95% CI 
= 0.36 to 1.04, if never vaccinated, p=0.07).     
 
Various demographic characteristics influenced patients’ seasonal influenza vaccination 
practices and beliefs.  Tables 6 and 7 summarize the relationships between patient age 
and influenza vaccination.  As seen in Table 6, adults under the age of 50, when 
compared to those over 50, had lower rates and odds of vaccination this year (15.4% vs. 
42.1%; OR = 0.25, 95% CI = 0.13 to 0.47, p<0.01), as well as in the past (40.4% vs. 
70.2%; OR 0.29, 95% CI = 0.15 to 0.54, p<0.01).  While age does not significantly 
impact one’s belief that they should be vaccinated or their plans to do so, the odds are 
greatest that the subgroup of patients 18-29 years old will accept a seasonal influenza 
vaccine in the ED (OR 1.67, 95% CI = 1.07 to 2.61, p=0.02), when compared to other 
age groups.  The majority of all patients younger than 65 would accept a vaccine in the 
ED (71.9% of 18-29 year-olds, 57.1% of 30-49 year-olds, 70% of 50-64 year-olds), 
although the odds were lowest for those who are 30-49 years old (OR 0.58, 95% CI = 
0.35 to 0.95, p=0.03) (Table 7).   
 
The relationship between racial/ethnic identities and vaccination status manifests in all 
non-white individuals having greater odds of never having been vaccinated than whites 
(OR 1.62, 95% CI = 1.03 to 2.55, p = 0.03) (Table 8).  Latino/Hispanic patients had the 
greatest odds of believing they should be vaccinated (OR 2.55, 95% CI = 1.39 to 4.64, 
p<0.01), which also translated to a greater willingness to accept the vaccine in the ED 
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(OR 2.89, 95% CI = 1.52 to 5.51, p <0.01).  This association, however, was not seen in 
other minority groups, with black patients having the lowest odds of accepting a vaccine 
in the ED (OR 0.57, 95%CI = 0.24 to 0.96, p=0.03) (Table 9).   
 
Neither sex nor educational backgrounds significantly influenced patients’ vaccination 
practices and beliefs this year, or in previous years. Although males in this study were 
less often vaccinated than females (16.2% vs 24.3%), the odds that sex influenced 
vaccination status were not statistically significant (OR 0.61, 95% CI = 0.36 to 1.03, p = 
0.06 for males).  Among groups with various levels of education, some non-statistically 
significant trends were seen among the non-vaccinated patients this year.  Those who 
never completed high school, or the equivalent, appear to have greater odds of believing 
they should be vaccinated (OR 1.75, 95% CI = 0.97 to 3.14, p = 0.06), having plans to be 
vaccinated (OR 1.28, 95% CI = 0.73 to 2.23, p = 0.39), or being willing to accept the 
vaccine during their current visit to the ED (OR 1.39, 95% CI = 0.76 to 2.44, p = 0.31). 
In fact, as patients reported completion of higher levels of education, the odds of their 
vaccine acceptance in the ED appeared to decrease (OR 1.13, 95% CI = 0.69 to 1.84, p = 
0.63 for high school graduates/GEDs; OR 0.60, 95% CI = 0.33 to 1.10, p = 0.09 for 
college graduates).  
 
Tables 10 through 14 demonstrate the relationship between patients’ access to the 
medical system and influenza vaccination.   Insurance status does affect vaccination 
practices among our patients, although the specific form of insurance may not matter 
(Tables 10, 11).  Patients with any form of insurance were more likely to have been 
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vaccinated this year (22.9% vs. 13.1%; OR 2.29, 95% CI = 1.14 to 4.63, p = 0.02) and in 
the past (48.6% vs. 36.9%; OR 1.65, 95% CI = 1.01 to 2.68, p = 0.04) (Table 10).  
Among those who had not been vaccinated this year, having government-issued/public 
insurance was associated with increased odds of planning to obtain the vaccine (OR 2.48, 
95% CI = 1.49 to 4.13, p<0.01).  Overall, the majority of unvaccinated patients would 
accept an influenza vaccine in the ED, regardless of their insurance status (63.6% of 
those with insurance, 61.6% of those without) (Table 11).   
 
Access to a primary care physician was associated with a greater likelihood and odds of 
vaccination this year (26.7% vs. 12.4%; OR 2.56, 95% CI = 1.44 to 4.55, p<0.01) and in 
the past (53.3% vs. 36.7%; OR 1.97, 95% CI= 1.28 to 3.04, p<0.01) (Table 12). When 
this survey was administered in November 2009, those patients who had been to their 
PMD within the previous two months had the greatest odds of already being vaccinated 
this year (OR 2.79, 95% CI = 1.53 to 5.08, p<0.01) (Table 13). Patients with PMDs who 
remained unvaccinated were also almost twice as likely to have plans to be vaccinated 
this season (51.5% vs. 26.4%; OR 2.97, 95% CI 1.77 to 4.99, p<0.01).  Most patients 
were willing to accept a vaccine in the ED, regardless of their access to primary care 
(62.9% vs. 64.9%) (Table 14). 
  
A total of 101 surveyed patients (28.9%) reported having some chronic medical condition 
that would place them at increased risk for complications of influenza, and eleven (3.2%) 
were pregnant or hoping to be pregnant during the coming flu season (Table 2).  Of those 
with chronic illness, chronic lung disease and diabetes were the most common, affecting 
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14.9% and 6.8% of the surveyed population, respectively.  As seen in Table 15, pregnant 
patients were not significantly more or less likely to have already been vaccinated this 
year.  However, patients with chronic illness had 1.79-times greater odds of vaccination 
this year than those with no medical indications for vaccination (95%CI = 1.03 to 3.12, 
p=0.04).  These increased odds were not, however, significantly present in previous 
years.  Neither pregnancy nor chronic medical illness significantly changed a patient’s 
odds of believing they should be vaccinated, having plans for vaccination, or being 
willing to accept the vaccine during their visit to the ED (Table 16).   
  
Patients in close contact with individuals at increased risk for influenza-related 
complications had consistently greater odds of previous vaccination (overall OR 1.85, 
95% CI = 1.12 to 3.04, p = 0.01), although the odds were not significant thus far for this 
vaccination season (OR 1.72, 95% CI = 0.89 to 3.33, p = 0.10) (Table 17).  Similarly, 
people with no known high-risk close contacts had significantly greater rates and odds of 
never having received a flu vaccine than those with high-risk contacts (63.4% vs 47.5%; 
OR 1.94, 95% CI = 1.18 to 3.17, p<0.01).  Of those who had not yet been vaccinated this 
season, individuals with any close contact with high-risk individuals were significantly 
more likely to believe they should be vaccinated (63.5% vs. 48.8%; OR 1.83, 95% CI = 
1.08 to 3.11, p=0.02), have plans to be vaccinated (42.5% vs. 27.5%; OR 1.95, 95% CI = 
1.10 to 3.45, p = 0.02) and be willing to accept the vaccine in the emergency department 
that day (69.5% vs. 50%; OR 2.28, 95% CI = 1.33 to 3.92, p<0.01) (Table 18).  These 
trends are all consistent regardless of whether patients’ contacts are at high-risk based on 
medical conditions or age.  However, the trends among unvaccinated healthcare workers 
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are reversed (OR 0.52, 95% CI = 0.23 to 1.17, p = 0.11, believing they should be 
vaccinated; OR 0.65, 95% CI = 0.27 to 1.55, p = 0.33, with plans to be vaccinated; OR 
0.50, 95% CI = 0.22 to 1.11, p = 0.08, accepting a vaccine in the ED).    
 
Patients who had not yet been vaccinated this year and would refuse the vaccine in the 
ED were asked to provide reasons for their refusal.  The summary of patients’ responses 
is presented in Table 19.  The most common reasons for vaccine refusal in the ED 
included belief that the vaccine will cause illness (25.3%), a lack of perceived need for 
the vaccine (24.1%), belief that one is healthy enough to fight off the flu without 
vaccination (18.4%), and concern of side effects from the vaccine (13.8%).  Less 
common responses included a fear of needles (8.1%), desire to consult one’s primary care 
doctor (6.9%), distrust of all vaccines (2.3%), and belief that the vaccine does not 
actually protect one from illness (1.1%).  No respondents reported a preference to get the 
vaccine elsewhere.   
 
Discussion 
Emergency departments serve as healthcare safety nets for much of the population, 
especially those who are young and uninsured.  Patients often present to the emergency 
department with primary care needs, however preventive care is rarely addressed during 
these visits.  Some vaccination practices have been successfully implemented in the 
emergency department, of which tetanus vaccination is most notable.  Since 2008, the 
American College of Emergency Physicians (ACEP) has acknowledged that “individuals 
at risk for [vaccine-preventable] diseases are often not appropriately immunized and that 
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EDs may be called upon to play a more prominent role in the event of an emerging (or 
biothreat) outbreak”31.  Given the antigenic shifts that annually create new influenza 
epidemics, and the high number of patients hospitalized for influenza-related illness each 
year, it is appropriate for emergency departments to consider the implementation of 
influenza vaccines in the care of their patients.  Several studies have found vaccination 
against seasonal influenza to be feasible in the emergency department for patients 
considered high-risk for complications of the flu based on their age or chronic medical 
conditions35-42, 44.  However, it is clear that high-risk individuals may not be sufficiently 
protected by the vaccine due to senescence of their immune system impairing their ability 
to develop humoral immunity.  For this reason, EDs should actually offer the vaccine to 
not only high-risk patients, but also the younger, healthier patients whose immunity 
against the flu could actually protect those at high-risk form initial exposure to the virus.  
 
This study evaluated the possibility of vaccinating patients in the Urgent Care area of the 
emergency department.  As demonstrated in Table 2, this patient population is generally 
young (mean age 36, ± SD 12.4 years, 84% younger than 50), healthy (71.1% with no 
chronic medical conditions), and without adequate access to primary medical care (48.4% 
without a PMD).  The overall good health and relatively mild chief complaints of the 
urgent care patient population limited medical contraindications to vaccination, such as 
moderate or severe febrile illness.   
 
The month of November was chosen for this study in order maximize opportunities for 
vaccination from other resources (e.g. primary care physicians, outside clinics or 
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pharmacies), while still making it available in the ED early enough to ensure proper 
immunoprotection before seasonal influenza hits the community.  The Advisory 
Committee on Immunization Practices recommends that health-care providers begin 
offering the vaccine by October, or immediately after it becomes available8.  Indeed, of 
those patients who have PMDs, the odds of vaccination were greater if they had seen 
their PMDs within the prior two months when vaccines should have been available (OR 
2.79, 95% CI = 1.53 to 5.08, p<0.01) (Table 13).  In 2009, November was actually very 
early in the immunization season due to a low vaccine supply.   This is reflected by the 
substantial growth in vaccination rates as the month progressed, which is demonstrated in 
Table 3.  Because greater than eighty percent of influenza seasons begin in January or 
later, with over sixty percent peaking in February, vaccinating patients during the month 
of November should allow adequate time for achieving sufficient antibody protection 
most years8.  
 
This study was conducted too early in the immunization season to fully compare 
vaccination rates for this year with those of previous years.  However, the rates of prior 
vaccination within this population were actually higher than the rates reported by the 
2009 National Health Interview Survey (NHIS)6. 40.4% of 18-49 year-olds, 68.6% of the 
50-64 year-olds, and 83.3% of those older than 65 reported prior vaccination in this 
population, while early results for the 2009 NHIS indicate rates of only 22.9%, 41.7%, 
and 67.6%, respectively, last year. Of note, the incongruence seen here may be attributed 
to the wording in this questionnaire, which asked about any previous vaccinations, rather 
than vaccination last year alone.   
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Overall, among the patients surveyed in our emergency department, those over the age of 
50 were significantly more likely to have already been vaccinated this year, and in 
previous years.  Patients younger than 50, who had not been included in vaccination 
recommendations prior to 2008, if they were in good health, had 3.28 (95% CI = 1.74 to 
6.21, p <0.01) times greater odds of never having been vaccinated before. Still, although 
they had lower vaccination rates this year and in the past, the majority recognize a need 
for influenza vaccination, and would be willing to accept the vaccine, if offered, in the 
ED (Table 6).  This is especially true for the 18-29 year-olds, who have the greatest odds 
of accepting a vaccine during their ED visit (OR 1.82, 95% CI 1.09 to 3.06, p=0.02) 
(Table 7).  Such results indicate that the vaccination of younger patients may indeed 
serve as a potential avenue for protecting older age groups from initial exposure to 
influenza virus in the community.  For patients older than 65, the 50% vaccination rate 
reported this year, and 83.3% reported for the past, may be compared to the 76.8% (95% 
CI = 74 to 79.6%) reported among Connecticut residents older than 65 in the 2007 
Behavioral Risk Factor Surveillance System (BRFSS) survey, or the 64.8% reported 
nationally in the 2009 NHIS6, 9.  These comparisons, however, are probably inaccurate as 
the small sample size of only six patients is unlikely to be an accurate representation of 
the local population. Regardless, it is clear that vaccination rates for this high-risk age 
group remain far below the Healthy People 2010 target of 90%11. In contrast, among 50-
to-64 year-olds, another age group recommended for universal vaccination, this year’s 
early vaccination rate of 41.2% actually appears promising, especially when compared to 
the 42.5% annual rate in the 2009 NHIS, and 46.6% Connecticut rate in the 2007 
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BRFSS6, 9.  The odds of this age group being vaccinated are in fact significantly greater 
than others (OR 3.65, 95% CI = 1.89 to 7.02, p<0.01).   
 
Racial/ethnic minorities make up a significant proportion of this surveyed ED population, 
with 66.5% of those surveyed being non-white (Table 2). Non-whites overall had 1.62-
times greater odds of never having been vaccinated than whites (95% CI = 1.03 to 2.55, p 
= 0.03) (Table 8).  Because non-whites together comprise the majority of this ED 
population, an obvious need is demonstrated by this discrepancy.  Among the non-
vaccinated patients of each racial/ethnic group, the majority responded favorably to the 
need for vaccination and would accept a vaccine in the ED (Table 9).  However, when 
considering the potential impact of influenza vaccine administration in the ED, one 
should take into account that while Hispanic/Latino patients do have the highest odds for 
vaccine acceptance (OR 2.89, 95% CI = 1.53-5.51, p<0.01), black patients have the 
lowest (OR 0.57, 95% CI = 0.34-0.96, p=0.03).  
 
Interestingly, the educational backgrounds of this patient population did not appear to 
independently influence their vaccination status.  While over three quarters of the patients 
surveyed had at least high school diplomas or the equivalent GED, they did not appear to 
be any more or less likely to accept a vaccine, believe that they should be vaccinated, or 
have plans to receive the vaccine this season.  In fact, the general trend suggests that 
although the majority of people with more formal education do respond positively to the 
idea of vaccination, they are at lower odds for believing they should be vaccinated, and 
for accepting a vaccine in the ED.   
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In contrast, healthcare coverage and access to a primary care physician do appear to be 
significant determinants of influenza vaccination.  According to this survey, a greater 
degree of need exists within in our population than that which is reported in the 2009 
National Health Interview Survey.  While nationally 15.1% (95% CI = 14.14% to 
16.08%) of those surveyed were uninsured, 24.1% of our patients reported having no 
form of health insurance (Table 2)6.  While we could not account for the effects of 
“underinsurance,” a complete lack of coverage clearly had adverse affects on an 
individual’s vaccination status.  Those who have any form of health insurance, whether 
private or government-sponsored, have 2.29-times greater odds than patients with no 
coverage of already being vaccinated this year (95% CI = 1.14 to 4.63, p=0.02), and 1.65 
times greater odds of having been vaccinated in the past (95% CI 1.01 to 2.68, p=0.04) 
(Table 10).  Although it affected their vaccination status up to that point, insurance status 
did not appear to be related to individuals’ acceptance of the influenza vaccine in the ED, 
with the overall majority agreeing to be vaccinated.  However, of all the patients who 
were not yet vaccinated this season, those with government sponsored insurance had the 
greatest odds of having plans to receive the vaccine elsewhere this year (OR 2.48, 95% 
CI = 1.49 to 4.13, p<0.01), a difference that may be attributed to the reimbursement for 
influenza vaccines by Medicare (Table 11). 
 
The discrepancy in access to primary care is also a significant factor in vaccination status.  
According to the 2009 NHIS, 14.6% of the population does not have a usual place to go 
for their medical care, an increase from 12.1% in 20036.  Of these, the least likely groups 
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to have places to go for primary care were 18-44 year-olds, who make up the majority of 
patients in the urgent care section of this emergency department, and Hispanic/Latino 
persons, who also comprise a significant proportion.  In this population, having a PMD 
was associated with a higher rate and greater odds of vaccination early this flu season 
(26.7% vs. 12.4%; OR 2.56, 95% CI = 1.44 to 4.55, p<0.01), as well as in the past 
(53.3% vs. 36.7%; OR 1.97, 95% CI = 1.28 to 3.04, p<0.01) (Table 12).  Among those 
with a PMD, their odds of vaccination were significantly greater if they visited their 
PMD in the previous two months (OR 2.79, 95% CI = 1.53 to 5.08, p<0.01), during 
which time they may have received the vaccine or been informed of its importance (Table 
13).  For those patients who had not yet been vaccinated, having a PMD also meant they 
were more likely to have plans to obtain the vaccine this year (51.5% vs. 26.4%; OR 
2.97, 95% CI = 1.77 to 4.99, p <0.01).  Yet despite these obvious advantages that primary 
care has on vaccination status, 44.4% of patients with PMDs still had never been 
vaccinated against the seasonal flu (Table 14).  Ultimately, although it affected outside 
access to vaccination, access to a PMD did not affect vaccine acceptance in the ED.   
 
While the aforementioned demographic factors influence vaccination in patients overall 
and should be considered as part of a mission to decrease the overall rates of illness and 
viral transmission, the medically high-risk patients remain a high priority for vaccine 
distribution.  The general ED population has an overall greater risk of complications from 
the flu, than the general US population34.  Among this study’s surveyed population 28.9% 
had a chronic medical condition and 3.2% had plans to be pregnant during the influenza 
season, making them at increased risk of complications of the flu. While those with a 
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chronic medical condition were more likely than healthy adults to have already been 
vaccinated this year, 48.5 had never before received a flu vaccine (Table 15).  As all the 
prior studies on ED influenza vaccinations suggest, this demonstrates a great need that 
emergency department providers could potentially address (Table 1).  Indeed ED 
vaccinations could help the medical community move toward achieving its Healthy 
People 2010 goal to vaccinate 60% of non-institutionalized high-risk 18-64 year old 
adults11.  
 
Of note, while the sample size of pregnant patients surveyed was quite small (n=11), EDs 
should not overlook the substantial need for vaccination of this group.  Pregnant women 
are at an increased risk for acute respiratory disease and cardiopulmonary hospitalizations 
secondary to influenza infection, especially during the third trimester of pregnancy45, 46.  
Still, vaccination rates for these women are alarmingly low, ranging from 3.5% 
(according to vaccine registries from 1998-2003) to 12.8% (according to a 2003 
telephone survey)47.  In a survey administered to obstetrician-gynecologists in 1999, only 
39% were in the practice of administering flu vaccines to their patients, suggesting that, 
despite attention to prenatal care, these women remain medically underserved48.  Thus the 
ED may make the most of patient visits by offering the vaccine to these women.   
 
Although vaccination programs in emergency departments may not be capable of 
reaching an adequate number of people to generate herd immunity in the community, 
they at least provide an opportunity to positively affect the health of those who often have 
limited contact with the healthcare system.  Using patient encounters in the emergency 
! "#!
department to vaccinate interested healthy adult patients also has the potential to prevent 
the spread of the influenza virus to the chronically ill, very young, and elderly in the 
community.  While this study did not find an association between high-risk contacts and 
vaccination this year, a clear difference in previous vaccination histories does exist 
between the two groups.  The odds of never having received a flu shot are in fact 
significantly greater for those with no known high-risk contacts.  Even among those with 
high-risk contacts, less than 50% reported vaccination.  Fortunately, those with high-risk 
close contacts who had not yet been vaccinated often at least recognized a need for their 
own immunization.  These patients had greater odds of believing they should be 
vaccinated, planning to be vaccinated this year, and accepting a vaccine in the ED (Table 
17).  Thus their visits to emergency departments also present an opportunity by which to 
protect those at greatest risk for complications of the flu.  Of note, these trends did not 
extend to unvaccinated healthcare workers, who were surprisingly less likely than non-
healthcare workers to believe they should be vaccinated, have plans to obtain a vaccine, 
or be willing to accept a vaccine in the ED.  Further analysis of this subgroup, however, 
is beyond the scope of this study.   
 
Patients expressed several reasons for vaccine refusal in the emergency department 
(Table 19).  Among them, beliefs that the flu shot will make them sick, that they are not 
at risk for the flu, or that they are healthy enough to fight off the flu, were the most 
common.  Concerns regarding vaccine side effects were also relatively high.  These 
barriers to vaccination highlight the need for patient education.  As described above, 
formal education has not been a positively influential contribution to patient knowledge 
! "#!
and beliefs about the flu vaccine.  Thus physicians and other healthcare providers must 
take on the role of our patients’ teachers, in order to allow for truly informed consent or 
dissent with regards to influenza vaccinations.  While many individuals are indeed not at 
high risk for complications of the flu, and are healthy enough to fight it, they should 
understand the important effect that their vaccination may have on protecting their friends 
and family who may be high-risk.  For those patients who site a fear of needles as their 
reason for vaccine refusal, the live attenuated influenza vaccine, in the form a nasal 
spray, is a safe alternative if they are healthy, not pregnant, and between the ages of two 
and 49 years8. 
 
Limitations 
A significant amount of bias may have affected our data.  First, the timing of the study 
may have contributed to sampling bias, which may ultimately limit comparison of 
vaccination rates this year, and in previous years.  As mentioned above vaccination rates 
reported so early in the season are lower than those that would be reported at the end.  
Thus this year’s vaccination rates are not comparable to those of previous years.   
Furthermore, while the reported rates of prior vaccination within this population may not 
be comparable to the rates reported by the 2009 National Health Interview Survey 
(NHIS) because the wording in this questionnaire addresses any previous vaccinations, 
rather than vaccinations last year alone6. 
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Because all data were obtained from patients’ personal accounts and memory, recall bias 
likely affected our outcomes pertaining to vaccination status this year and in previous 
years.   Furthermore, since patient records were not reviewed, it is likely that some 
patients at high-risk for complications of the flu were not accurately identified as having 
known chronic medical conditions.  Likewise, patients’ knowledge of the health of their 
household contacts may be inaccurate, thus limiting the understanding of vaccination 
practices among patients with close contacts at high-risk for complications of the flu.   
  
Unique to this year, a number of complications arose from a concurrent H1N1 outbreak.  
This produced a fair amount of validity bias, and subsequently limited the 
generalizability of these results to other seasonal influenza vaccination seasons.  First, an 
early shift in vaccine production to manufacturing of H1N1 vaccines created a shortage 
of seasonal influenza vaccines for the course of this study in November 2009.  This 
affected results by decreasing the number of patients already vaccinated this early in the 
typical influenza season.  If compared to the month of November in previous years when 
vaccine supply was ample, the 20% vaccination rate this year may be quite low.  The 
limited vaccine supply also affected this study by altering it from its original form, which 
would have involved actual vaccine administration to patients willing to accept it in the 
ED.  Instead, researchers were forced to limit the study to a questionnaire surveying 
potential vaccine acceptance.  One may assume that this hypothetical acceptance rate 
would drop if patients were faced with the option of actually receiving a flu shot.   
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Beyond affecting seasonal influenza vaccine availability, the H1N1 pandemic may have 
also influenced our study by skewing public perception and understanding of influenza.  
This would introduce further recall bias because patients who reported having been 
vaccinated this year may have only received the H1N1 vaccine, which was more readily 
available than the seasonal influenza vaccine for some time.  Additionally, patients may 
not have had a clear understanding that there are two separate vaccines, and that the 
seasonal vaccine does not prevent illness from H1N1.  In such a case, their increased 
vigilance regarding “the flu” may have falsely elevated their beliefs that they should be 
vaccinated, plans for vaccination, and willingness to accept the vaccine in the ED.  In 
order to minimize this effect, patient education was provided regarding the differences 
between the two forms of influenza and their respective vaccines.  Results summarized in 
Table 5 affirm that patients who had been vaccinated in the past had significantly greater 
odds of being vaccinated this year, believing that they should be vaccinated, having plans 
to receive the vaccine, and being willing to accept the vaccine in the ED.  In contrast, 
those who had never been vaccinated had lower odds of vaccine acceptance.  So despite 
the increased public awareness of “the flu,” individuals’ perceptions of vaccination this 
year did not necessarily deviate from those of previous years without H1N1.  
 
This study is also limited in its applicability because it only measured acceptability of 
influenza vaccines among patients in the ED, and not the healthcare workers who would 
be administering the vaccine.  Additionally, because the vaccine was not actually 
administered, the results of this study do not demonstrate or evaluate the feasibility of 
vaccine administration in the ED.  When considering the implementation of an influenza 
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vaccination program, one must take into account that the distribution of this survey was 
done by an individual specifically designated to that task, and it only reached a 
convenience sample of patients.  While physician assistants and nurse practitioners in the 
department were originally expected to help distribute the survey during their patient 
encounters, their time constraints with patient care made them unable or unwilling to do 
so.  If vaccines were actually administered in the ED by fulltime staff, one would imagine 
this additional step in patient care to likewise be hindered by other constraints on the time 
of healthcare providers.  A recent survey from Fernandez, et al. at Boston Medical Center 
found that while 73% of attending physicians “agreed/strongly agreed” that influenza 
vaccines should be administered to patients in the ED, only 54% of residents and 32% or 
nurses felt the same way49.  When the ED staff who are most likely to administer the 
vaccine are the least receptive to including that role in their patients’ care, the feasibility 
of vaccination programs can be greatly hindered.  Indeed some of the previous studies 
evaluating influenza vaccinations in the ED found that the acceptance of the vaccine was 
greater than the actual vaccine administration (Table 1).  Beyond provider constraints, 
additional barriers to feasibility may be financial.  Significant burdens may be placed on 
the EDs and hospitals funding formal vaccination programs, as well as the patients and 
their insurance companies paying for the vaccine.   
 
Lastly, when evaluating the potential impact of these results on future vaccine 
distribution in the ED, one must consider that the overall effect the vaccinations will vary 
from year to year, given the occasional inability to match the vaccine to the circulating 
virus.  Each year, the vaccine is composed of three expected antigens from influenza A 
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(H3N2), influenza A (H1N1), and influenza B, which are based on anticipated point 
mutations in hemagglutinin and neuraminidase viral genes8, 16.  These strains are chosen 
annually by the Food and Drug Administration’s Vaccine and Related Biological 
Products Advisory Committee based on available epidemiological surveillance data50.  
Because vaccine production begins during the months of February and March prior to the 
coming flu vaccine, prediction of upcoming antigenic shift may be inaccurate, with 
efficacy in healthy young people ranging from 0-50% if the vaccine-virus match is poor, 
to 70-90% if the match is good8, 51.  While ED vaccinations in a “good match” year could 
prevent illness in many of our patients and their high-risk close contacts, such positive 
effects may not be seen if the match is poor.   
 
Future Directions 
This study demonstrated a significant interest among patients for accepting a seasonal 
influenza vaccine in the emergency department.  However, as mentioned above, because 
the study was limited to a survey, rather than actual administration of the vaccine, true 
acceptance rates are not known, nor is the feasibility of vaccine administration in the ED.  
Future studies should focus on vaccine administration to interested patients, as part of 
normal departmental functioning.  This would allow for further identification of potential 
methods and barriers to not only acceptability, but also feasibility of vaccinating 
emergency department patients.  As demonstrated in other trials, useful methods to 
maximize delivery of the vaccine to interested patients include some form of standing 
orders within the system and/or a designated nurse for vaccine administration36-40. While 
designating staff for this specific purpose is likely not feasible or affordable in the long 
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term, ACIP does agree that standing orders should exist for all hospitalized patients to be 
vaccinated against seasonal influenza, and this practice could likewise succeed if 
formally implemented in the ED8.  Acceptability by patients would also likely benefit 
from the availability of both the intranasal and intramuscular forms of vaccine.   
 
Conclusions 
Unvaccinated adult patients would accept the seasonal influenza vaccine in the ED.  A 
shortage of seasonal influenza vaccines and an increased vigilance secondary to a 
concurrent H1N1 outbreak may have influenced the acceptability of this study.  However, 
implementing availability of universal seasonal influenza vaccinations in the ED has the 
potential to reach two important patient populations –those who are at high risk for 
complications associated with influenza infection, and those who are young and healthy 
but serve as potential sources for viral transmission to their high-risk close contacts.  
While the majority of all non-vaccinated patients would accept the vaccine in the ED, 
factors associated with greatest odds of vaccine acceptance included age younger than 50, 
Hispanic/Latino ethnicity, and close contact with high-risk individuals.  As these groups 
make up a significant portion of the ED population, their vaccination could indeed make 
a difference in the health of their communities.   
 
Emergency physicians are often faced with addressing severe medical consequences of 
conditions that are preventable by adequate primary medical care. As the economy 
continues to struggle, and universal healthcare coverage continues to be politically 
elusive, the association between lack of vaccinations and lack of healthcare coverage will 
! "#!
increasingly affect our patients.  Therefore, as part of proper medical care and service for 
our patients, distribution of annual influenza vaccines should be a part of this important 
patient encounter with the medical system.   
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Authors 
(publication 
year) 
Study 
period 
Location 
 
% at 
high-
risk  
Up To 
Date 
Vaccine 
Status  
% of high risk 
patients willing to 
accept an influenza 
vaccine in ED, % 
actually receiving 
the vaccine* 
Barriers to 
vaccine 
acceptability 
Cassidy W, 
et al. 
(2009)40 
Dec 5, 
2005 – 
March 5, 
2006 
Louisiana State 
University, 
Baton Rouge, 
LA, USA 
76% 25% 54% accepted,  
39% vaccinated 
 
Rimple D, 
et al. 
(2006)39 
Dec 1-21, 
2003 
University of 
New Mexico, 
Albuquerque, 
NM, USA 
69% 16% 66% accepted,  
66% vaccinated 
• Perceived lack of 
need 
Pearson E, 
et al. 
(2005)38 
Nov  
1-30, 
2001 
Sir Mortimer B 
Davis Jewish 
Hospital 
(McGill), 
Montreal, 
Quebec, Canada 
36% 35% 71% accepted, 
65% vaccinated 
• Questions about 
vaccine benefits 
• Concern of side 
effects 
• Want to discuss 
with their PMD 
Kapur A, 
Tenenbein 
M (2000)41 
March 
1996  
(one 
week/ED) 
4 EDs in 
Winnipeg, 
Manitoba, 
Canada 
64.5% 45%  59.3% accepted 
(Not vaccinated) 
• 72% perceived 
lack of need 
• 60% concern of 
side effects 
• 22% want to 
discuss with 
their PMD 
Chiasson 
AM, Rowe 
P (2000)44 
Nov 6 – 
Dec 10, 
1997 
Prince George 
Regional 
Hospital, Prince 
George, BC, 
Canada 
27.6% 47.2% 43% vaccinated  
Slobodkin 
D, et al. 
(1998)37  
Oct 21, 
1996 – 
Dec 2, 
1996 
Cook County 
Hospital, 
Chicago, IL, 
USA 
29.9% 21% 71% accepted,  
62% vaccinated 
• 39% perceived 
lack of need 
• 29% concern of 
adverse reaction 
• 14% believe it 
will cause the 
flu/pneumonia 
• 8% believe the 
vaccine does not 
work 
• 7% want to 
receive the 
vaccine 
elsewhere 
• 3% want further 
advice 
• 16.6% other 
! "#!
Wrenn K, et 
al. (1994)42 
1994 Vanderbilt 
University, 
Nashville, TN, 
USA 
Not 
reported 
57% 54% accepted  
(Not vaccinated) 
• Never informed 
of need for 
vaccine 
• History of adverse 
reaction 
Rodriguez 
RM, Baraff 
LJ (1993)36 
Mid Oct– 
Mid Dec, 
1992!
UCLA, Los 
Angeles, CA, 
USA 
Not 
reported 
36.8% 53.6% accepted, 
50% vaccinated 
• 34% wanted to 
discuss with 
their PMD 
• 22% believe the 
vaccine does not 
work 
• 15% concern of 
adverse reaction!
Polis, MA, 
et al 
(1987)35 
Aug-Dec 
1986 
George 
Washington 
University 
Medical Center, 
Washington 
D.C., USA 
Not 
reported 
47.8% 
(ever 
vaccinated) 
59.3% accepted 
(Not vaccinated) 
• 27% concern of 
side effects 
• History of flu-
like symptoms 
after prior 
vaccine 
 
*Among patients without contraindications to the vaccine 
 
 
This table represents all prior studies of influenza vaccinations in the emergency 
department, all of which were focused on the vaccination of individuals at high risk for 
complications of the flu.  Studies were conducted in both Canada and the United States, 
with varying rates of high-risk patients (27.6-76%) and up-to-date annual vaccinations 
(16-47.2%).  The acceptance rates for the vaccine varied from 54% to 71%, and while not 
all studies actually administered the vaccine, actual ED vaccination rates ranged from 43-
65%. 
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The survey distributed to and completed by patients in the Urgent Care section of the 
Yale-New Haven Hospital Emergency Department.   
! "#!
!"#$%&'(&)*++",-&./&0*,1%-&,%02.30%0!
! $%&'()!*+,"-! .!%/!$%&'(!
45%&6-%",07&89%"3&:;&-%",0<&)=&>'?@& ! !
!!0123-!! 0,0! ,45#!
!!,62"-! 070! "75,!
!!#627"! #0! 0"57!
!!7#8! 7! 054!
!!9%:;<=>!&?';!#6!! 3-3! 1,54!
!!#6!';@!%(@=>! #4! 075,!
! ! !
)%A& & ! !
!!A'(=! 0-4! #75"!
!!B=C'(=! 0#3! ",57!
! ! !
B"C%DEFG3HCHF-& ! !
!!D?E&=!F;%;2GEHI';EJK! 064! ,654!
!!L('JM!F;%;2GEHI';EJK! 037! ,750!
!!GEHI';EJNO'&E;%! -#! 3453!
!!P&?=>! 00! ,53!
!!*%;2Q?E&=! 3,3! 775#!
! ! !
I30*,"3C%&)F"F*0& ! !
!!R>ES'&=!T;H:>';J=! -,! 3757!
!!U&'&=NV%S=>;C=;&!FR:W(EJK! 076! "751!
!!X;Y!?='(&?!E;H:>';J=! 3#,! 435"!
!!*%;=! 1"! 3"50!
! ! !
EJ*C"FH.3&$%1%$& ! !
!!*%;2?E<?!HJ?%%(!<>'@:'&=! 1,! 3,51!
!!GE<?!HJ?%%(!<>'@:'&=NVZ[! 0-,! ##5#!
!!\%((=<=!<>'@:'&=! 4,! 365-!
!!X((!?E<?!HJ?%%(!<>'@:'&=HNVZ[! 377! 4753!
! ! !
K"CCH3"FH.3&0F"F*0& ! !
!!]=J=ES=@!S'JJE;=!&?EH!Y='>! 7-! 0-51!
!!^'JJE;'&=@!E;!I>=SE%:H!Y='>H! 0#1! "#5,!
!!!!!!!!GEH&%>Y!%/!'@S=>H=!>='J&E%;!/%((%QE;<!!
!!!!!!!!E;/(:=;_'!S'JJE;'&E%;H!E;!&?=!I'H&!F066.!!!!!!!
!!!!!!!!>=I%>&=@!`/(:a!%>!/(:2(EM=!HYCI&%CHK!
36! 0357!
!!*=S=>!S'JJE;'&=@!! 016! #057!
!!$?E;M!&?=Y!H?%:(@!W=!!
!!^'JJE;'&=@!F%/!;+316!:;S'JJE;'&=@K!
077! #-5,!
!!G'S=!I(';H!&%!W=!S'JJE;'&=@!!!!!!
!!&?EH!Y='>!F%/!;+316!:;S'JJE;'&=@K!
064! ,153!
!!D%:(@!'JJ=I&!S'JJE;=!E;!Z[!!
!!F%/!;+316!:;S'JJE;'&=@K!
04-! ;:?L&
! ! !
M"1%&"&2,H+",-&+%JHC"$&J.CF.,& 016! #057!
! ! ! !
9%JHC"$&H3JHC"FH.30&/.,&1"CCH3"FH.3& ! !
!!R>=<;';&! 00! ,53!
!!\?>%;EJ!C=@EJ'(!J%;@E&E%;! 060! 315-!
! ! !
M%"$FGC",%&N.,O%,& ,"! -51!
& ! !
P$.0%&C.3F"CF&NHFG&"F&,H0O&2%,0.3607&#%$.N& 3#7!! 4,5"!
!!\?>%;EJ'((Y!E((!I=>H%;! 10! ! 3,5#! !
!!X&!>EHM!'<=!<>%:I!Fb#!Y='>H)!!c#6!Y='>HK! 3,4! 7150!
!!b7!C%;&?!%(@! #-! 075-!
! "#!
The above table summarizes the data obtained from patient-completed surveys, including 
demographic breakdown, vaccination status, medical indications for annual vaccination, 
and close contact with people at high risk for complications of influenza.    
!
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Table 3: Vaccination rates over time 
 
Dates Number 
surveyed 
Number reporting 
vaccination this 
year (%) 
November 2-
15 
203 33 (16%) 
November 16-
30 
149 36 (24%) 
Vaccination rates increased over the course of this study, from 16% during the first half 
to 24% during the second.   
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Table 4:  Vaccination beliefs/practices of patients who have never been vaccinated 
(N=180) 
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This table summarizes the vaccination status and interests of patients who have never 
been vaccinated.  Also includes data on traditional indications for influenza vaccination 
among these patients.  
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Table 5: Previous vaccination status compared to current vaccination beliefs and 
practices 
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Patients’ current vaccination practices and beliefs were measured in relation to their 
vaccination history.  The first three columns show that patients vaccinated this year, those 
who believe they should be vaccinated, those with plans to be vaccinated, and those 
willing to accept a vaccine in the emergency department were all likely to have been 
vaccinated in previous years.  The second three columns show that those same patient 
groups were unlikely to have never been vaccinated.  Because the “never vaccinated” 
group excludes all patients vaccinated this year, that data has been omitted.  Overall, 
history of previous vaccination did affect the odds that a patient would respond favorably 
to vaccination now.   
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Table 6: Age and vaccination status 
 
Age 
(years) 
Vaccinated 
this year 
(%) 
 n=69 
p-value Odds Ratio  
(95% 
Confidence 
interval) 
Vaccinated 
in previous 
years  (%) 
n=158 
p-
value 
Odds Ratio 
(95% 
Confidence 
Interval) 
Never 
vaccinated 
(%) n=180 
p-
value 
Odds Ratio  
(95% 
Confidence 
Interval) 
18-29, 
n=131 
17  
(12.9) 
0.01 0.48 
(0.26,0.87) 
50  
(38.2)  
0.04 
 
0.63 
(0.40,0.98) 
78  
(59.5) 
0.02 1.67 
(1.07,2.61) 
30-49, 
n=161 
28  
(17.4)  
0.29 0.75  
(0.44,1.28) 
68  
(42.2) 
0.32 0.81 
(0.53,1.23) 
86  
(53.4) 
0.56 1.13 
(0.74,1.73) 
50-64, 
n=51 
21  
(41.2)  
<0.01 3.65 
(1.89,7.02) 
35  
(68.6)  
<0.01 
 
3.11 
(1.63,5.95) 
15  
(29.4) 
<0.01 0.34 
(0.17,0.65) 
!65,  
n=6 
3  
(50)  
0.06 4.20 
(0.82,21.5) 
5  
(83.3)  
0.06 6.21 
(0.71,54.5) 
1  
(16.7) 
0.08 0.18 
(0.02,1.60) 
          
18-49, 
n=292 
45  
(15.4) 
<0.01 0.25 
(0.13,0.47) 
118 
(40.4) 
<0.01 0.29 
(0.15,0.54) 
164  
(56.2) 
<0.01 3.28 
(1.74,6.21) 
!50, 
n=57 
24  
(42.1) 
<0.01 3.99 
(2.12,7.53) 
40  
(70.2)  
<0.01 3.47 
(1.85,6.52) 
16  
(28.1) 
<0.01 0.30 
(0.16,0.58) 
 
The likelihood of vaccination among various age groups is demonstrated here.  The first 
three columns show the number and percent of patients vaccinated this year in the given 
age groups, as well as the p-values and odds ratios with 95% confidence intervals 
demonstrating the significance of the likelihood of vaccination in these age groups.  The 
second and third sets of columns demonstrate the same information in relation to 
vaccination in previous years and never being vaccinated, respectively.  
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Table 7: Age and vaccination beliefs/practices among patients who have not been 
vaccinated this year (N=280) 
Age 
(years) 
Believe 
they should 
be 
vaccinated 
(%), n=166 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Plans to be 
vaccinated 
(%),  
n=107 
p-
value 
Odds Ratio 
(95% 
Confidence 
Interval) 
Would 
accept a 
vaccine in 
the ED (%), 
n=179 
p-value Odds Ratio  
(95% 
Confidence 
Interval) 
18-29, 
n=114 
72  
(63.2) 
0.28 1.31 
(0.80,2.15) 
49  
(43.0) 
0.17 1.40 
(0.86,2.29) 
82 (71.9) 0.02 1.82 
(1.09,3.06) 
30-49, 
n=133 
73  
(54.9) 
0.17 0.71 
(0.44,1.16) 
44  
(32.1) 
0.11 0.67 
(0.41,1.09) 
76 (57.1) 0.03 0.58 
(0.35,0.95) 
50-64, 
n=30 
20  
(66.7) 
0.38 1.42 
(0.64,3.18) 
13  
(43.3) 
0.54 1.27 
(0.59,2.74) 
21 (70.0) 0.46 1.36 
(0.60,3.10) 
65+, 
n=3 
1  
(33.3) 
0.36 0.34 
(0.03,3.82) 
1 
(33.3) 
0.86 0.81 
(0.07,9.04) 
0 (0) 0.02 0 
          
18-49, 
n=247 
145  
(58.7) 
0.59 0.81 
(0.38,1.73) 
93  
(37.7) 
0.60 0.82 
(0.39,1.71) 
158 (64.0) 0.97 1.01 
(0.48,2.16) 
!50, 
n=33 
21  
(63.6) 
0.59 1.23 
(0.58,2.61) 
14  
(42.4) 
0.60 1.22  
(0.58,2.55) 
21  
(63.6) 
0.97 0.99 
(0.46,2.10) 
 
Among patients who were not vaccinated this year, the likelihood of interest in 
vaccination in various age groups is demonstrated here.  The first three columns show the 
number and percent of patients believing they should be vaccinated in the given age 
groups, as well as the p-values and odds ratios with 95% confidence intervals 
demonstrating the significance of the likelihood of vaccination in these age groups.  The 
second and third sets of columns demonstrate the same information in relation to plans to 
be vaccinated this year and willingness to accept a vaccine in the emergency department, 
respectively.  
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Table 8: Race/Ethnicity and vaccination status 
 
Race/ 
Ethnicity 
Vaccinated 
this year 
(%), n=69 
p-value Odds Ratio 
(95% 
Confidence 
interval) 
Vaccinated 
in previous 
years (%), 
n=158 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Never 
vaccinated 
(%), n=180 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
White  
n=107 
17  
(15.9) 
0.23 0.69 
(0.38,1.26) 
55  
(51.4) 
0.13 1.43 
(0.90,2.26) 
47  
(43.9) 
0.06 0.64 
(0.40,1.01) 
Black  
n=126 
27  
(21.4) 
0.56 1.18 
(0.68,2.02) 
55  
(43.7) 
0.65 0.91 
(0.58,1.40) 
68  
(54.0) 
0.50 1.16 
(0.75,1.80) 
Latino/ 
Hispanic 
n=95 
20  
(21.1) 
0.71 1.11 
(0.62,2.00) 
40  
(42.1) 
0.47 0.84 
(0.52,1.35) 
53  
(55.8) 
0.34 1.26 
(0.78,2.03) 
Other 
n=11 
2  
(18.2) 
0.89 0.90 
(0.19,4.27) 
3  
(27.3) 
0.22 0.44 
(0.12,1.71) 
8  
(72.7) 
0.15 2.57 
(0.67,9.93) 
          
All non-
white, 
n=232 
49  
(21.1) 
0.37 1.30 
(0.73,2.31) 
98  
(42.2) 
0.11 0.69 
(0.44,1.08) 
129  
(55.6) 
0.03 1.62 
(1.03,2.55) 
 
The likelihood of vaccination among various race/ethnic groups is demonstrated here.  
The first three columns show the number and percent of patients vaccinated this year in 
the given race/ethnic groups, as well as the p-values and odds ratios with 95% confidence 
intervals demonstrating the significance of the likelihood of vaccination in these groups.  
The second and third sets of columns demonstrate the same information in relation to 
vaccination in previous years and never being vaccinated, respectively.  
!
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Table 9: Race/Ethnicity and vaccination beliefs/practices among patients who have 
not been vaccinated this year (N=280) 
Race/ 
Ethnicity 
Believe 
they should 
be 
vaccinated 
(%), n=166 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Plans to be 
vaccinated 
(%), n=107 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Would 
accept a 
vaccine in 
the ED (%), 
n=179 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
White  
n=90 
49 (54.4) 0.26 0.75 
(0.45,1.24) 
32 (35.6) 0.53 0.85 
(0.50,1.43) 
57 (63.3) 0.89 0.96 
(0.57,1.62) 
Black 
n=99 
54 (54.5) 0.23 0.74 
(0.45,1.22) 
37 (37.4) 0.83 0.95 
(0.57,1.57) 
55 (55.6) 0.03 0.57 
(0.34,0.96) 
Latino/ 
Hispanic 
n=75 
56 (74.7) <0.01 2.55 
(1.39,4.64) 
34 (45.3) 0.14 1.50 
(0.87,2.57) 
60 (80.0) <0.01 2.89 
(1.52,5.51) 
Other  
n=9 
3 (33.3) 0.11 0.33 
(0.08,1.37) 
1 (11.1) 0.09 0.19 
(0.02,1.60) 
3 (33.3) 0.05 0.27 
(0.07,1.12) 
          
All  
non-
white  
n=183 
113 
(61.7) 
0.25 1.34 
(0.81,2.21) 
72 (39.3) 0.59 1.15 
(0.69,1.91) 
118 (64.5) 0.79 1.07 
(0.64,1.79) 
 
Among patients who were not vaccinated this year, the likelihood of interest in 
vaccination for various race/ethnic groups is demonstrated here.  The first three columns 
show the number and percent of individuals of various race/ethnic groups patients 
believing they should be vaccinated, as well as the p-values and odds ratios with 95% 
confidence intervals demonstrating the likelihood of vaccination.  The second and third 
sets of columns demonstrate the same information in relation to plans to be vaccinated 
this year and willingness to accept a vaccine in the emergency department, respectively.  
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Table 10: Insurance status and vaccination status 
 
Insurance 
status 
Vaccinated 
this year 
(%), n=69 
p-value Odds Ratio 
(95% 
Confidence 
interval) 
Vaccinated 
in previous 
years (%),  
n=158 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Never 
vaccinated 
(%), n=180 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Private, 
n=93 
21 
(22.6) 
0.43 1.26 
(0.71,2.26) 
45 
(48.4) 
0.48 1.19 
(0.74,1.91) 
45 
(48.3) 
0.47 0.84 
(0.52,1.35) 
Public,  
n=160 
37 
(23.1) 
0.16 1.46 
(0.86,2.48) 
78  
(48.8) 
0.23 1.30 
(0.85,1.99) 
77  
(48.1) 
0.23 0.77 
(0.51,1.18) 
None, 
n=84 
11 
(13.1) 
0.08 0.54 
(0.27,1.08) 
31 
(36.9) 
0.08 0.64 
(0.38,1.06) 
50 
(59.5) 
0.09 1.53 
(0.93,2.52) 
          
Any 
insurance, 
n=253 
58  
(22.9) 
0.02 2.29 
(1.14,4.63) 
123 
(48.6) 
0.04 1.65 
(1.01,2.68) 
122 
(48.2) 
0.04 0.61 
(0.38,0.99) 
 
The likelihood of vaccination among individuals with various levels of health insurance 
is demonstrated here.  The first three columns show the number and percent of patients 
vaccinated this year in the given insurance status groups, as well as the p-values and odds 
ratios with 95% confidence intervals demonstrating the significance of the likelihood of 
vaccination in these groups.  The second and third sets of columns demonstrate the same 
information in relation to vaccination in previous years and never being vaccinated, 
respectively.  
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Table 11: Insurance status and vaccination beliefs/practices among patients who 
have not been vaccinated this year (N=280) 
Insurance 
status 
Believe 
they should 
be 
vaccinated 
(%), n=166 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Plans to be 
vaccinated 
(%), n=107 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Would 
accept a 
vaccine in 
the ED 
(%) n=179 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Private, 
n=72 
34  
(47.2) 
0.02 0.52 
(0.30,0.89) 
21  
(29.2) 
0.07 0.58 
(0.33,1.05) 
40 (55.6) 0.09 0.62 
(0.36,1.08) 
Public, 
n=123 
80  
(65.0) 
0.07 1.57 
(0.96,2.57) 
61  
(49.6) 
<0.01 2.48 
(1.49,4.13) 
84 (68.3) 0.15 1.44 
(0.87,2.37) 
None, 
n=73 
46  
(63.0) 
0.45 1.24 
(0.71,2.14) 
22  
(30.1) 
0.10 0.62 
(0.34,1.10) 
45 (61.6) 0.64 0.88 
(0.50,1.52) 
          
Any 
insurance, 
n=195 
114 
(58.5) 
0.67 0.89 
(0.53,1.51) 
82  
(42.1) 
0.05 1.74 
(1.00,3.02) 
124 (63.6) 0.86 0.95 
(0.56,1.62) 
 
Among patients who were not vaccinated this year, the likelihood of interest in 
vaccination among individuals with various levels insurance is demonstrated here.  The 
first three columns show the number and percent these patients who believe they should 
be vaccinated, as well as the p-values and odds ratios with 95% confidence intervals 
demonstrating the likelihood of vaccination.  The second and third sets of columns 
demonstrate the same information in relation to plans to be vaccinated this year and 
willingness to accept a vaccine in the emergency department, respectively.  
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Table 12: Access to primary care and vaccination status 
Have a 
PMD? 
Vaccinated 
this year 
(%), n=69 
p-value Odds Ratio 
(95% 
Confidence 
interval) 
Vaccinated 
in previous 
years (%), 
n=158 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Never 
vaccinated 
(%), n=180 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Yes 
n=180 
48  
(26.7) 
<0.01 2.56 
(1.44,4.55) 
96 (53.3) <0.01 1.97 
(1.28,3.04) 
80  
(44.4) 
<0.01 0.55 
(0.36,0.85) 
No 
n=169 
21  
(12.4) 
<0.01 0.39 
(0.22,0.69) 
62 (36.7) <0.01 0.51 
(0.33,0.78) 
100  
(59.2) 
<0.01 1.81 
(1.18,2.79) 
 
The likelihood of vaccination among individuals with and without primary care 
physicians is demonstrated here.  The first three columns show the number and percent of 
patients with and without PMDs who were vaccinated this year, as well as the p-values 
and odds ratios with 95% confidence intervals demonstrating the significance of the 
likelihood of vaccination in these groups.  The second and third sets of columns 
demonstrate the same information in relation to vaccination in previous years and never 
being vaccinated, respectively.  
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Table 13: Last visit with a primary care physician (N= 149 responses of 180 
individuals reporting to have primary medical doctors [83%]) 
 
Of the 180 patients with primary care doctors, 149 (83%) provided information on their 
last visit with that physician.  69 (49%) of these patients had seen their primary care 
doctor within the last two months, and 24 (35%) of them had been vaccinated.  This 
corresponded with a 2.79 odds ratio (95% CI=1.53-5.08, p<0.01) for vaccination among 
patients who visited their PMD within the last two months.  The odds of vaccination 
decreased as patients were further temporally removed from their last medical visit.   
!
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Table 14: Access to primary care and vaccination beliefs/practices among patients 
who have not been vaccinated this year (N=280) 
Have a 
PMD? 
Believe 
they should 
be 
vaccinated 
(%), n=166 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Plans to be 
vaccinated 
(%), n=107 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Would 
accept a 
vaccine in 
the ED (%), 
n=179 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Yes 
n=132 
83  
(62.9) 
0.25 1.33 
(0.82,2.15) 
68  
(51.5) 
<0.01 2.97 
(1.77,4.99) 
83 (62.9) 0.73 0.92 
(0.56,1.50) 
No 
n=148 
83  
(56.1) 
0.25 0.75 
(0.47,1.22) 
39  
(26.4) 
<0.01 0.34 
(0.20,0.57) 
96 (64.9) 0.73 1.09 
(0.67,1.78) 
 
Among patients who were not vaccinated this year, the likelihood of interest in 
vaccination for individuals with and without primary care physicians is demonstrated 
here.  The first three columns show the number and percent of these patients believing 
they should be vaccinated, as well as the p-values and odds ratios with 95% confidence 
intervals demonstrating the likelihood of vaccination.  The second and third sets of 
columns demonstrate the same information in relation to plans to be vaccinated this year 
and willingness to accept a vaccine in the emergency department, respectively.  
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Table 15: Patients with medical indications for vaccination and vaccination status 
 
Medical 
indication 
Vaccinated 
this year 
(%), n=69 
p-value Odds Ratio 
(95% 
Confidence 
interval) 
Vaccinated 
in previous 
years (%), 
n=158 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Never 
vaccinated 
(%), n=180 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Pregnant 
n=11 
2  
(18.2) 
0.90 0.90 
(0.19, 4.29) 
      
Chronic 
medical 
illness, 
n=101 
26  
(26.7) 
0.04 1.79  
(1.03, 3.12) 
49 
(48.5) 
0.44 1.20 
(0.75,1.91) 
49  
(48.5%) 
0.47 0.84 
(0.53,1.33) 
No 
medical 
indications 
n=245 
42  
(17.1) 
0.06 0.59  
(0.34, 1.03) 
109  
(44.5) 
0.65 0.90 
(0.57,1.43) 
128  
(52.2) 
0.70 1.09 
(0.69,1.73) 
 
The likelihood of vaccination among individuals with medical conditions that place them 
at increased risk of complication from influenza infection is demonstrated here.  The first 
three columns show the number and percent of patients vaccinated this year in the each 
group with specified medical indications for vaccination, as well as the p-values and odds 
ratios with 95% confidence intervals demonstrating the significance of the likelihood of 
vaccination in these age groups.  The second and third sets of columns demonstrate the 
same information in relation to vaccination in previous years and never being vaccinated, 
respectively.  
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Table 16: Patients with medical indications for seasonal influenza vaccination and 
vaccination beliefs/practices among patients who have not been vaccinated this year 
(N=280) 
Medical 
Indication 
Believe 
they should 
be 
vaccinated 
(%), n=166 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Plans to be 
vaccinated 
(%), n=107 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Would 
accept a 
vaccine in 
the ED (%), 
n=179 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Pregnant, 
n=9 
7  
(77.8) 
0.25 2.47 
(0.50,12.2) 
5  
(55.6) 
0.27 2.10 
(0.55,8.05) 
8  
(88.9) 
0.12 4.61 
(0.56,37.9) 
Chronic 
medical 
illness, 
n=74 
49  
(66.2) 
0.16 1.49 
(0.85,2.60) 
29  
(39.2) 
0.84 1.06 
(0.61,1.83) 
49  
(67.6) 
0.45 1.24 
(0.71,2.19) 
No 
medical 
indications 
n=203 
115 
(56.7) 
0.15 0.67 
(0.38,1.16) 
77  
(37.9) 
0.87 0.96 
(0.56,1.64) 
126  
(62.1) 
0.29 0.74 
(0.42,1.30) 
 
Among patients who were not vaccinated this year, the likelihood of interest in 
vaccination for individuals with medical conditions placing them at increased risk for 
complications of the flu is demonstrated here.  The first three columns show the number 
and percent of these patients believing they should be vaccinated, as well as the p-values 
and odds ratios with 95% confidence intervals demonstrating the likelihood of 
vaccination.  The second and third sets of columns demonstrate the same information in 
relation to plans to be vaccinated this year and willingness to accept a vaccine in the 
emergency department, respectively.  
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Table 17: Contact with high-risk individuals and vaccination status 
High-risk 
contacts 
Vaccinated 
this year 
(%), n=69 
p-value Odds Ratio 
(95% 
Confidence 
interval) 
Vaccinated 
in previous 
years  (%) 
n=158 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Never 
vaccinated 
(%), n=180 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Close 
contact 
with 
chronic 
disease, 
n=81 
22  
(27.2) 
0.05 1.77 
(0.98, 3.18) 
48  
(59.3) 
<0.01 2.10 
(1.26,3.51) 
30  
(37.0) 
<0.01 0.46 
(0.27,0.78) 
Close 
contact 
<5yrs or 
>50yrs, 
n=237 
52  
(21.9) 
0.15 1.55 
(0.85, 2.84) 
116  
(48.9) 
0.04 1.64 
(1.03,2.61) 
116  
(48.9) 
0.02 0.57 
(0.36,0.90) 
Close 
contact 
<6mo,  
n=59 
12  
(20.3) 
0.90 1.04 
(0.52, 2.10) 
      
Work in 
health care 
n=34 
7  
(20.6) 
0.92 1.05 
(0.44, 2.51) 
20  
(58.8) 
0.11 1.80 
(0.87,3.71) 
13  
(38.2) 
0.11 0.56 
(0.27,1.16) 
          
All 
contacts of 
high-risk 
individuals 
n=256 
56  
(21.9) 
0.10 1.72 
(0.89, 3.33) 
126  
(49.2) 
0.01 1.85 
(1.12,3.04) 
121  
(47.3) 
<0.01 0.52 
(0.32,0.85) 
No high-
risk 
contacts 
n=93 
13  
(14.0) 
0.10 0.58 
(0.30, 1.12) 
32  
(34.4) 
0.01 0.54 
(0.33,0.89) 
59  
(63.4) 
<0.01 1.94 
(1.18,3.17) 
 
The likelihood of vaccination among of individuals in contact with people at increased 
risk for complications of influenza is demonstrated here.  The first three columns show 
the number and percent of patients vaccinated this year in the contact groups, as well as 
the p-values and odds ratios with 95% confidence intervals demonstrating the 
significance of the likelihood of vaccination in these groups.  The second and third sets of 
columns demonstrate the same information in relation to vaccination in previous years 
and never being vaccinated, respectively. Because contact with babies younger than 6 
months old was not necessarily known for prior vaccination season, the columns related 
to previous vaccination histories were omitted for this variable.   
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Table 18: Contact with high-risk individuals for patients who have not been 
vaccinated this year (N=280) 
High-risk 
contacts 
Believe 
they should 
be 
vaccinated 
(%), n=166 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Plans to be 
vaccinated 
(%), n=107 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Would 
accept a 
vaccine in 
the ED (%), 
n=179 
p-value Odds Ratio 
(95% 
Confidence 
Interval) 
Close 
contact 
with 
chronic 
disease, 
n=59 
38  
(64.4) 
0.33 1.35 
(0.74,2.45) 
25 
(42.4) 
0.43 1.27 
(0.71,2.28) 
40  
(67.8) 
0.44 1.27 
(0.69,2.34) 
Close 
contact 
<5yrs or 
>50yrs, 
n=185 
117  
(63.2) 
0.05 1.65 
(0.99,2.74) 
79  
(42.7) 
0.02 1.85 
(1.08,3.17) 
130  
(70.3) 
<0.01 2.27 
(1.34,3.82) 
Close 
contact 
<6mo, 
n=47 
30  
(63.8) 
0.49 1.26 
(0.66,2.41) 
22  
(46.8) 
0.18 1.53 
(0.81,2.89) 
34 (72.3) 
 
0.19 1.59 
(0.79,3.18) 
Work in 
health care  
n=27 
12  
(44.4) 
0.11 0.52 
(0.23,1.17) 
8  
(29.6) 
0.33 0.65 
(0.27,1.55) 
13  
(48.1) 
0.08 0.50 
(0.22,1.11) 
          
All 
contacts of 
high-risk 
individuals 
n=200 
127  
(63.5) 
0.02 1.83 
(1.08,3.11) 
85  
(42.5) 
0.02 1.95 
(1.10,3.45) 
139  
(69.5) 
<0.01 2.28 
(1.33,3.92) 
No high-
risk 
contacts 
n=80 
39  
(48.8) 
0.02 0.55 
(0.32,0.93) 
22  
(27.5) 
0.02 0.51 
(0.29,0.91) 
40  
(50.0) 
<0.01 0.44 
(0.26,0.75) 
 
Among patients who were not vaccinated this year, the likelihood of interest in 
vaccination for individuals in contact with people at high risk for complication is 
demonstrated here.  The first three columns show the number and percent of these 
patients believing they should be vaccinated, as well as the p-values and odds ratios with 
95% confidence intervals demonstrating the likelihood of vaccination.  The second and 
third sets of columns demonstrate the same information in relation to plans to be 
vaccinated this year and willingness to accept a vaccine in the emergency department, 
respectively.  
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Of the 101 unvaccinated patients who would not accept a seasonal influenza vaccine in 
the emergency department, 97 (96%) provided reasons for their refusal.  This table 
demonstrates the number of people providing each response as a reason for refusal, and 
the percent of all respondents providing the same response.  
 
 
 
